Displaying 1 - 18 of 18
| Active Ingredient | ANTIHISTAMINICS |
| Therapeutic Class | ANTIHISTAMINICS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | CARDIOVASCULAR DRUGS |
| Therapeutic Class | CARDIOVASCULAR DRUGS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | SODIUM BICARBONATE |
| Therapeutic Class | ALKALINIZING AGENTS |
| Indications | Metabolic acidosis |
| Caution |
Do not over-correct. It is better to undercorrect, e.g. from a pH of 7.0 to 7.2 only , initially , hypernatremia, cerebral edema, intracranial hemorrhage. C.f. prescribing in renal disease p. 36. |
| Dose Range | Slow i.v inj: 8.4% solution used in 50-100ml aliquots only according to plasma pH and electrolytes. 5% infusion in cardiac arrest only . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | SODIUM LACTATE CO. |
| Therapeutic Class | ALKALINIZING AGENTS |
| Indications | Diabetic coma, diminished alkali reserve. |
| Caution | Lactic acidosis. C.f. prescribing in renal disease p.36. |
| Dose Range | The dosage depends on age, weight and clinical condition of the patient. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | HYALURONIDASE |
| Therapeutic Class | ENZYMES |
| Indications |
As an adjunct to increase absorption and dispersion of injected drugs, subcutaneous infusions. Use controversial. |
| Caution | Sensitivity to hyaluronidase occasionally occurs. |
| Dose Range | 1500 units s.c. or i.m. mixed with injection fluid. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | BRIMONIDINE |
| Therapeutic Class | EENT ALPHA ADRENERGIC AGONISTS |
| Indications | Ocular hypotension and glaucoma. |
| Caution | Blurring. lid retraction, headache, fatigue, drowsiness. TO BE USED ONLY IN THOS E PATIENTS UNRESPONS IVE TO OTHER PREPARATIONS . |
| Dose Range | 1 drop 3 times daily. See BDS supply protocols pg. 11. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | TIMOLOL |
| Therapeutic Class | EENT BETA ADRENERGIC AGENTS |
| Indications |
Treatment of chronic op en angle glaucoma. May be used alone or in conjunction with miotics or adrenaline. |
| Caution | Use with great caution in patients taking systemic beta blockers. Contraindicated in asthmatics. Danger of bradycardia. |
| Dose Range | Adult: 1 drop twice daily into eye. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | TIMOLOL EX |
| Therapeutic Class | EENT BETA ADRENERGIC AGENTS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DEFERASIROX |
| Therapeutic Class | HEAVY METAL ANTAGONISTS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DESFERRIOXAMINE MESYLATE |
| Therapeutic Class | HEAVY METAL ANTAGONISTS |
| Indications | Iron-The heavy metal antagonists have the property of forming complexes with heavy metals and preventing or reversing the binding of metallic cations to body ligands |
| Caution | Initially up to 15 mg/kg/hour, max. 80 mg/kg in 24 hours, dose to be reduced after 4–6 hours, in severe cases, higher doses may be given.Arthralgia; bone disorder; fever; growth retardation; headache; More ... |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DIMERCAPROL |
| Therapeutic Class | HEAVY METAL ANTAGONISTS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | PENICILLAMINE |
| Therapeutic Class | HEAVY METAL ANTAGONISTS |
| Indications | Acute copper (or lead) poisoning, Wilson's disease. Third line drug for rheumatoid arthritis (to reduce cystine levels). |
| Caution |
Epigastric pain, nausea, rash c.f. prescribing in renal disease p. 34 |
| Dose Range | Adult: 1-2g daily in divided doses (In R. A: 125mg-250mg with doses increases over a 3-4 mth period to a maximum of 1.5g). Pediatric: 2.5-10mg/kg twice daily . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | SKIN AND MUCOUS MEMBRANE PREPARATIONS |
| Therapeutic Class | SKIN-MUCOUS MEMBRANE PREPARATIONS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ADMIN SET |
| Therapeutic Class | MEDICAL DEVICES |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ADMIN SET ADULT |
| Therapeutic Class | MEDICAL DEVICES |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ADMIN SET GLYCINE |
| Therapeutic Class | MEDICAL DEVICES |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ADMIN SET PAED |
| Therapeutic Class | MEDICAL DEVICES |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | BOTTLES |
| Therapeutic Class | MEDICAL DEVICES |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |